Integrated Bioinformatics Analysis Reveals Marker Genes and Potential Therapeutic Targets for Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a rare cardiovascular disease with very high mortality rate. The currently available therapeutic strategies, which improve symptoms, cannot fundamentally reverse the condition. Thus, new therapeutic strategies need to be established. Our research analyzed thr...
Main Authors: | Aoqi Li, Jin He, Zhe Zhang, Sibo Jiang, Yun Gao, Yuchun Pan, Huanan Wang, Lenan Zhuang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/9/1339 |
Similar Items
-
The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis
by: Weibin Wu, et al.
Published: (2022-12-01) -
Bioinformatics analysis of the immune cell infiltration characteristics and correlation with crucial diagnostic markers in pulmonary arterial hypertension
by: Guili Lian, et al.
Published: (2023-08-01) -
Identification of <i>JPX-RABEP1</i> Pair as an Immune-Related Biomarker and Therapeutic Target in Pulmonary Arterial Hypertension by Bioinformatics and Experimental Analyses
by: Qian Gong, et al.
Published: (2022-12-01) -
Animal Models of Pulmonary Arterial Hypertension and Their Application in Drug Research
by: YU Jiahui, et al.
Published: (2023-08-01) -
Screening and Identification of Therapeutic Targets for Pulmonary Arterial Hypertension Through Microarray Technology
by: Qing Li, et al.
Published: (2020-07-01)